Safety and efficacy of autologous endothelial progenitor cells transplantation in children with idiopathic pulmonary arterial hypertension: Open-label pilot study

Pediatric Transplantation

Volumn 12, Issue 6, 2008, Pages 650-655

  Zhu, Jun Hui ^b   Wang, Xing Xiang ^c   Zhang, Fu Rong ^c   Shang, Yun Peng ^c   Tao, Qian Min ^c   Zhu, Jian Hua ^c   Chen, Jun Zhu ^a,c  

^a Zhejiang University ^*  (China)

^b ZHEJIANG UNIVERSITY   (China)

^c ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Cell transplantation; Endothelial progenitor cells; Idiopathic pulmonary arterial hypertension; Pediatrics; Stem cells; Transplantation

Indexed keywords

ADOLESCENT; ARTICLE; AUTOLOGOUS ENDOTHELIAL PROGENITOR CELL TRANSPLANTATION; CLINICAL ARTICLE; EXERCISE; EXERCISE TEST; FEASIBILITY STUDY; FEMALE; HEART CATHETERIZATION; HUMAN; IDIOPATHIC DISEASE; LUNG HEMODYNAMICS; MALE; PATIENT SAFETY; PILOT STUDY; PULMONARY HYPERTENSION; SCHOOL CHILD; SIX MINUTE WALK DISTANCE TEST; STEM CELL TRANSPLANTATION; TREATMENT INDICATION; TREATMENT OUTCOME;

ADOLESCENT; CHILD; ENDOTHELIAL CELLS; EXERCISE; FEMALE; HEART CATHETERIZATION; HEMODYNAMICS; HUMANS; HYPERTENSION, PULMONARY; INFUSIONS, INTRAVENOUS; MALE; MONOCROTALINE; PILOT PROJECTS; STEM CELL TRANSPLANTATION; TRANSPLANTATION, AUTOLOGOUS;

EID: 49349116828     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2007.00863.x     Document Type: Article

References (38)

1. D'Alonzo GE, Barst RJ, Ayres SM, et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med 1991: 115: 343 349.
2. Rosenzweig EB, Barst RJ. Idiopathic pulmonary arterial hypertension in children. Curr Opin Pediatr 2005: 17: 372 380.
3. Rich S, Kaufmann E, Levy PS. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. N Engl J Med 1992: 327: 76 81.
4. Higenbottam T, Wheeldon PW, Wallwork J. Long-term treatment of primary pulmonary hypertension with continuous intravenous epoprostenol (prostacyclin). Lancet 1984: 1: 1046 1047.
5. Barst RJ, Rubin LJ, McGoon MD, et al. Survival in primary pulmonary hypertension with long-term continuous intravenous prostacyclin. Ann Intern Med 1994: 121: 409 415.
6. Yung D, Widlitz AC, Rosenzweig EB, Kerstein D, Maislin G, Barst RJ. Outcomes in children with idiopathic pulmonary arterial hypertension. Circulation 2004: 110: 660 665.
7. Nagaya N, Kangawa K, Kanda M, et al. Hybrid cell-gene therapy for pulmonary hypertension based on phagocytosing action of endothelial progenitor cells. Circulation 2003: 108: 889 895.
8. Zhao YD, Courtman DW, Deng Y, Kugathasan L, Zhang O, Stewart DJ. Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells: Efficacy of combined cell and eNOS gene therapy in established disease. Circ Res 2005: 96: 442 450.
9. Takahashi M, Nakamura T, Toba T, Kaiwara N, Kato H, Shimizu Y. Transplantation of endothelial progenitor cells into the lung to alleviate pulmonary hypertension in dogs. Tissue Eng 2004: 10: 771 779.
10. Tateishi-Yuyama E, Matsubara H, Murohara T, et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: A pilot study and a randomised controlled trial. Lancet 2002: 360: 427 435.
11. Strauer BE, Brehm M, Zeus T, et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002: 106: 1913 1918.
12. Assmus B, Schachinger V, Teupe C, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 2002: 106: 3009 3017.
13. Schachinger V, Assmus B, Britten MB, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: Final one-year results of the TOPCARE-AMI Trial. J Am Coll Cardiol 2004: 44: 1690 1699.
14. Wang XX, Zhang FR, Shang YP, et al. Transplantation of autologous endothelial progenitor cells may be beneficial in patients with idiopathic pulmonary arterial hypertension: A pilot randomized controlled trial. J Am Coll Cardiol 2007: 49: 1566 1571.
15. Rich S, Dantzker DR, Ayres SM, et al. Primary pulmonary hypertension: A national prospective study. Ann Intern Med 1987: 107: 216 223.
16. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: Guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002: 166: 111 117.
17. Kalka C, Masuda H, Takahashi T, et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A 2000: 97: 3422 3427.
18. Chen JZ, Zhu JH, Wang XX, et al. Effects of homocysteine on number and activity of endothelial progenitor cells from peripheral blood. J Mol Cell Cardiol 2004: 36: 233 239.
19. Bowyer JJ, Busst CM, Denison DM, Shinebourne EA. Effect of long term oxygen treatment at home in children with pulmonary vascular disease. Br Heart J 1986: 55: 385 390.
20. Karatza AA, Bush A, Magee AG. Safety and efficacy of Sildenafil therapy in children with pulmonary hypertension. Int J Cardiol 2005: 100: 267 273.
21. Rosenzweig EB, Widlitz AC, Barst RJ. Pulmonary arterial hypertension in children. Pediatr Pulmonol 2004: 38: 2 22.
22. Clabby ML, Canter CE, Moller JH, Bridges ND. Hemodynamic data and survival in children with pulmonary hypertension. J Am Coll Cardiol 1997: 30: 554 560.
23. Boucek MM, Novick RJ, Bennett LE, Fiol B, Keck BM, Hosenpud JD. The Registry of the International Society of Heart and Lung Transplantation: First official pediatric report - 1997. J Heart Lung Transplant 1997: 16: 1189 1206.
24. Runo JR, Loyd JE. Primary pulmonary hypertension. Lancet 2003: 361: 1533 1544.
25. Tuder RM, Cool CD, Yeager M, Taraseviciene-Stewart L, Bull TM, Voelkel NF. The pathobiology of pulmonary hypertension. Endothelium. Clin Chest Med 2001: 22: 405 418.
26. Hill JM, Zalos G, Halcox JP, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003: 348: 593 600.
27. Walter DH, Rittig K, Bahlmann FH, et al. Statin therapy accelerate reendothelialization: A novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 2002: 105: 3017 3024.
28. Asahara T, Murohara T, Sullivan A, et al. Isolation of putative endothelial progenitor cells for angiogenesis. Science 1997: 275: 964 967.
29. Peichev M, Naiyer AJ, Pereira D, et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 2000: 95: 952 958.
30. Gill M, Dias S, Hattori K, et al. Vascular trauma induces rapid but transient mobilization of VEGFR2+AC133+ endothelial precursor cells. Circ Res 2001: 88: 167 174.
31. Rafii S. Circulating endothelial precursors: Mystery, reality, and promise. J Clin Invest 2000: 105: 17 19.
32. Szmitko PE, Fedak PW, Weisel RD, Stewart DJ, Kutryk MJ, Verma S. Endothelial progenitor cells: New hope for a broken heart. Circulation 2003: 107: 3093 3100.
33. Murohara T, Ikeda H, Duan J, et al. Transplanted cord blood-derived endothelial progenitor cells augment postnatal neovascularization. J Clin Invest 2000: 105: 1527 1536.
34. Kocher AA, Schuster MD, Szabolcs MJ, et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 2001: 7: 430 436.
35. Takahashi T, Kalka C, Masuda H, et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999: 5: 434 438.
36. Aicher A, Brenner W, Zuhayra M, et al. Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling. Circulation 2003: 107: 2134 2139.
37. Anderson SA, Glod J, Arbab AS, et al. Noninvasive MR imaging of magnetically labeled stem cells to directly identify neovasculature in a glioma model. Blood 2005: 105: 420 425.
38. Boyle AJ, Schulman SP, Hare JM. Is stem cell therapy ready for patients? Stem cell therapy for cardiac repair ready for the next step. Circulation 2006: 114: 339 352.